This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Alonso, D. R. Articles by Minick, C. R. Search for Related Content PubMed PubMed Citation Articles by Alonso, D. R. Articles by Minick, C. R.

American Journal of Pathology, Vol 87, 415-442, Copyright © 1977 by American Society for Investigative Pathology

REGULAR ARTICLES

Studies on the pathogenesis of atheroarteriosclerosis induced in rabbit cardiac allografts by the synergy of graft rejection and hypercholesterolemia

DR Alonso, PK Starek and CR Minick

Heterotopic cardiac allografts were placed in the necks of 48 rabbits. In rabbits that were not immunosuppressed, allografts beat as long as 12 days, while in immunosuppressed rabbits allografts beat as long as 101 days. Coronary arterial lesions in donor hearts of rabbits fed a lipid-poor diet were found in arteries of all sizes and were mainly proliferative without fatty change. In cholesterol-fed rabbits, arterial lesions were similarly distributed, but the majority of lesions in longer surviving transplants were fatty-proliferative and some bore close resemblance to chronic human coronary atheroselerosis. In contrast to findings in cardiac homotransplants, only occasional predominantly fatty lesions were induced in small intramyocardial arteries of cholesterol-fed recipients. By electron microscopy, early arterial lesions in allografts were characterized by platelet aggregates in widened junctions between endothelial cells, sloughing of endothelium without intimal thickening but with adherence of platelets to the denuded arterial wall, and platelets deep within essentially normal media. Platelets were also seen adhering to the lining cells overlying the thickened intima of more advanced arterial lesions. Results indicate that immunologic arterial injury due to allograft rejection acting in synergy with hypercholesterolemia resulting from a dietary supplement of cholesterol can lead to rapidly developing atherosclerosis. Observations of early and evolving lesions indicate that endothelial injury and platelet interaction with the arterial wall are early and continuing events and may be of primary importance in the pathogenesis of experimental graft-induced atheroarteriosclerosis. In man, similar mechanisms may be involved in the pathogenesis of graft- induced athererosclerosis and in other instances of atherosclerosis. (Am J Pathol 87:415-442, 1977).

This article has been cited by other articles:

				R. S. Poston, M. Billingham, E. G. Hoyt, J. Pollard, R. Shorthouse, R. E. Morris, and R. C. Robbins Rapamycin Reverses Chronic Graft Vascular Disease in a Novel Cardiac Allograft Model Circulation, July 6, 1999; 100(1): 67 - 74. [Abstract] [Full Text] [PDF]

				H. O. Andersen, P. Holm, S. Stender, B. F. Hansen, and B. G. Nordestgaard Dose-Dependent Suppression of Transplant Arteriosclerosis in Aorta-Allografted, Cholesterol-Clamped Rabbits : Suppression Not Eliminated by the Cholesterol-Raising Effect of Cyclosporine Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2515 - 2523. [Abstract] [Full Text]

				C. Shi, W.-S. Lee, M. E. Russell, D. Zhang, D. L. Fletcher Jr, J. B. Newell, and E. Haber Hypercholesterolemia Exacerbates Transplant Arteriosclerosis via Increased Neointimal Smooth Muscle Cell Accumulation : Studies in Apolipoprotein E Knockout Mice Circulation, October 21, 1997; 96(8): 2722 - 2728. [Abstract] [Full Text]

				S. Ravalli, M. Szabolcs, A. Albala, R. E. Michler, and P. J. Cannon Increased Immunoreactive Endothelin-1 in Human Transplant Coronary Artery Disease Circulation, November 1, 1996; 94(9): 2096 - 2102. [Abstract] [Full Text]

				Y. Furukawa, A. Matsumori, T. Hirozane, and S. Sasayama Angiotensin II Receptor Antagonist TCV-116 Reduces Graft Coronary Artery Disease and Preserves Graft Status in a Murine Model : A Comparative Study With Captopril Circulation, January 15, 1996; 93(2): 333 - 339. [Abstract] [Full Text]

				M. C. Deng, S. Bell, P. Huie, F. Pinto, S. A. Hunt, E. B. Stinson, R. Sibley, B. M. Hall, and H. A. Valantine Cardiac Allograft Vascular Disease : Relationship to Microvascular Cell Surface Markers and Inflammatory Cell Phenotypes on Endomyocardial Biopsy Circulation, March 15, 1995; 91(6): 1647 - 1654. [Abstract] [Full Text]

				K. Ueda, A. Herskowitz, T. A. Pearson, J. M. Dillman, M. Suzuki, H. Adachi, R. Omoto, W. A. Baumgartner, and B. A. Reitz Dipyridamole and Nifedipine--Studies on Their Protective Effects for Heart Graft Arterial Stenosis Vascular and Endovascular Surgery, June 1, 1990; 24(5): 326 - 334. [Abstract] [PDF]

				J.-s. Yao, J.-f. Wang, H.-y. Li, T.-m. Liu, Wu Giang, and W.-z. Duan Pathogenesis of Atherosclerosis: I: Role of the Nervous System Angiology, August 1, 1988; 39(8): 714 - 719. [Abstract] [PDF]